New publication on Oncology Research and Treatment
Precision Oncology in Northern Germany – Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards
Precision Oncology in Northern Germany – Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards
Spatial Mapping of Gonad Development in DSD
PD-L1–linked spatial decoupling of tumour–immune interactions in EBV-positive DLBCL
Characterisation of leydig cells in individuals with genetic defects of androgen signalling
A new variant in the 3’-UTR of the SRD5A2 gene leads to highly efficient exonisation of an Alu element and contributes to 5α-steroid reductase type 2 deficiency
Exploring gonadal development in differences of sex development using spatial transcriptomics
Characterization of testicular developmental defects in MYRF-associated DSD
Exonisation of an Alu element in the 3’-UTR contributes to SRD5A2 deficiency
Cutaneous dysbiosis in inherited ichthyoses/epidermal differentiation disorders: a prospective case-control study
A liquid biopsy-centered, pan-cancer, open next generation sequencing panel to support clinical decision-making (LION panel)
C70-02 Targetable Cytokines Promote Dysmorphic Mucosa via Cell-Cell Interactions Revealed by Single-Cell RNA-Sequencing in Post-Covid Syndrome
Genetic Profiling of Autoimmune Diseases and Exploring Clusters Through Polygenic Risk Score Analysis Using Cohort Data from the UK Biobank
Mitochondrial toxins cause widespread downregulation of pathways in X-linked dystonia-parkinsonism patient-derived neurons
Biomarker Identification of Myocardial Infarction Subtypes
Organoids serve as viable in vitro model for functional precision medicine for mesonephric-like adenocarcinoma of the ovary
P102 Beyond hinge motifs: the molecular basis of transporter-mediated kinase inhibitor resistance
Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain Metastases
Multi-Omics Characterization of a KIF1C Structural Variant in a Patient with a Complex Movement Disorder Partially Responsive to Deep Brain Stimulation
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |